Background: Patients of polycystic ovarian syndrome (PCOS) often suffer from psychiatric co morbidities, such as anxiety and depression. Indian literature regarding prevalence of these disorders in PCOS patients is scanty.
Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. [1] It affects 5-10% women in reproductive age group. [2] It is characterized by amenorrhea, oligomenorrhea, anovulation, infertility, obesity, hirsutism, and acne. These symptoms lead to anxiety, depression, impaired sexual functioning, and marital and social maladjustment. [3] Prevalence of anxiety in women with PCOS ranges from 34% to 57%. [4, 5] Prevalence of depression in PCOS varies similar findings. Rassi et al. [11] observed depression in 26% patients whereas Hollinrake et al. [12] found 21% prevalence of depression in PCOS. Some authors have reported depression prevalence as high as 40-45%. [13, 14] In an Indian study, 23% PCOS patients had major depressive disorder compared to 7.5% controls. [15] Depression in PCOS may be related to change in physical appearance as obesity, acne, and hirsutism lead to negative perception of self and social withdrawal, which culminates into depression.
Our study observed high prevalence of anxiety disorder in PCOS. Similar findings have been observed by earlier researchers. [13, 14] High anxiety level in PCOS may be due to infertility, loss of sexuality, acne, hirsutism, and obesity. [16] [17] [18] 
Conclusion
Our study demonstrates high level of anxiety and depression in PCOS patients. polycystic ovaries on ultrasound scan, (2) clinical signs of hyperandrogenism, and (3) >35 days interval between menstrual periods and/or amenorrhea defined as absence of vaginal bleeding for at least 6 months. Exclusion criteria were having adrenal hyperplasia, thyroid dysfunction, psychiatric diagnosis or taking psychiatric medications, and hyperprolactinemia.
Measures
Hospital anxiety and depression scale (HADS) was used to assess anxiety and depression. [8] HADS is a reliable instrument to screen for clinically significant anxiety and depression in patients attending a general medical clinic. It is also a valid measure of the severity of these mood disorders. This questionnaire contains 14 questions, including 7 each for rating anxiety and depression. The scale has been found to be equivalent to Hamilton anxiety or depressive scales in reliability and validity. A score of 0-7 on either subscale is regarded as normal, 8-10 as suggestive of presence of mild alterations, and that of 11 or higher indicates probable presence of the particular mood disorder or anxiety disorder. HADS has a correlation of 0.6-0.8 with other questionnaires for anxiety and depression, such as Beck Depression Inventory and Clinical Anxiety Scale. A Hindi version was used, though it has not been validated.
A semi-structured questionnaire was used to gather information about socioeconomic status and clinical symptoms. Clinical symptoms assessment included menstrual history; reproductive history; BMI; body hair, which were assessed using Ferriman-Gallwey scoring system [9] ; and acne, which were assessed on global acne grading system (GAGS). [10] Data were expressed as proportions.
Result
In this study of 200 women of PCOS mean age (SD) was 25.42 (3.68) and most of women had education level of 10-12 years. Interval between menstruation days was variable in majority and more than two-thirds had never been pregnant. Sociodemographic and clinical characteristics are shown in Table 1 .
Of the participants, 28% (56) demonstrated increased anxiety scores (HADS anxiety subscale ≥11) and 11% (22) showed increased depression scores (HADS depression subscale ≥11). There were 17% (34) who scored above the cutoff for both anxiety and depression subscales.
Discussion
Goal of this study was to assess prevalence of anxiety and depression in PCOS patients. We found high prevalence of depression in PCOS. Earlier studies have also reported
